Search research articles
Contact Us
Filters
Showing results (1-10 of 29) with videos related to
Page
of 3
Sort By:
Drug News & Perspectives
|
April 22, 2006
Retinoic acid receptor-related orphan receptor alpha as a therapeutic target in the treatment of dyslipidemia and atherosclerosis
Heidelinde Jakel, Jamila Fruchart-Najib, Jean-Charles Fruchart
Current Atherosclerosis Reports
|
July 17, 2020
Selective Peroxisome Proliferator-Activated Receptor Alpha Modulators (SPPARMα): New Opportunities to Reduce Residual Cardiovascular Risk in Chronic Kidney Disease?
Jean-Charles Fruchart, Michel P Hermans, Jamila Fruchart-Najib
Current Atherosclerosis Reports
|
January 4, 2021
Selective Peroxisome Proliferator-Activated Receptor Alpha Modulators (SPPARMα) in the Metabolic Syndrome: Is Pemafibrate Light at the End of the Tunnel?
Jean-Charles Fruchart, Michel P Hermans, Jamila Fruchart-Najib, et al.
Clinical Chemistry and Laboratory Medicine
|
July 20, 2007
Apolipoprotein A-V gene polymorphisms in subjects with metabolic syndrome
Loredan Stefan Niculescu, Jamila Fruchart-Najib, Jean-Charles Fruchart, et al.
Annals of Medicine
|
February 2, 2006
Is apolipoprotein A5 a novel regulator of triglyceride-rich lipoproteins?
Heidelinde Jakel, Maxime Nowak, Audrey Helleboid-Chapman, et al.
Atherosclerosis
|
July 26, 2005
Postprandial increase of plasma apoAV concentrations in Type 2 diabetic patients
Valérie Pruneta-Deloche, Gabriel Ponsin, Laure Groisne, et al.
Diabetologia
|
May 3, 2005
Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetes
Anne Hiukka, Jamila Fruchart-Najib, Eeva Leinonen, et al.
Diabetes Care
|
May 9, 2007
The increase of apolipoprotein A-V during postprandial lipemia parallels the response of triglyceride-rich lipoproteins in type 2 diabetes: no relationship between apoA-V and postheparin plasma lipolytic activity
Juhani Kahri, Jamila Fruchart-Najib, Niina Matikainen, et al.
Circulation Research
|
July 29, 2008
Atheroprotective effect of human apolipoprotein A5 in a mouse model of mixed dyslipidemia
Roxane M Mansouri, Eric Baugé, Philippe Gervois, et al.
Cell Research
|
June 15, 2006
Glucose regulates LXRalpha subcellular localization and function in rat pancreatic beta-cells
Audrey Helleboid-Chapman, Stéphane Helleboid, Heidelinde Jakel, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 29) with videos related to
Sort By:
Page
of 3
Drug News & Perspectives
|
April 22, 2006
Retinoic acid receptor-related orphan receptor alpha as a therapeutic target in the treatment of dyslipidemia and atherosclerosis
Heidelinde Jakel, Jamila Fruchart-Najib, Jean-Charles Fruchart
Current Atherosclerosis Reports
|
July 17, 2020
Selective Peroxisome Proliferator-Activated Receptor Alpha Modulators (SPPARMα): New Opportunities to Reduce Residual Cardiovascular Risk in Chronic Kidney Disease?
Jean-Charles Fruchart, Michel P Hermans, Jamila Fruchart-Najib
Current Atherosclerosis Reports
|
January 4, 2021
Selective Peroxisome Proliferator-Activated Receptor Alpha Modulators (SPPARMα) in the Metabolic Syndrome: Is Pemafibrate Light at the End of the Tunnel?
Jean-Charles Fruchart, Michel P Hermans, Jamila Fruchart-Najib, et al.
Clinical Chemistry and Laboratory Medicine
|
July 20, 2007
Apolipoprotein A-V gene polymorphisms in subjects with metabolic syndrome
Loredan Stefan Niculescu, Jamila Fruchart-Najib, Jean-Charles Fruchart, et al.
Annals of Medicine
|
February 2, 2006
Is apolipoprotein A5 a novel regulator of triglyceride-rich lipoproteins?
Heidelinde Jakel, Maxime Nowak, Audrey Helleboid-Chapman, et al.
Atherosclerosis
|
July 26, 2005
Postprandial increase of plasma apoAV concentrations in Type 2 diabetic patients
Valérie Pruneta-Deloche, Gabriel Ponsin, Laure Groisne, et al.
Diabetologia
|
May 3, 2005
Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetes
Anne Hiukka, Jamila Fruchart-Najib, Eeva Leinonen, et al.
Diabetes Care
|
May 9, 2007
The increase of apolipoprotein A-V during postprandial lipemia parallels the response of triglyceride-rich lipoproteins in type 2 diabetes: no relationship between apoA-V and postheparin plasma lipolytic activity
Juhani Kahri, Jamila Fruchart-Najib, Niina Matikainen, et al.
Circulation Research
|
July 29, 2008
Atheroprotective effect of human apolipoprotein A5 in a mouse model of mixed dyslipidemia
Roxane M Mansouri, Eric Baugé, Philippe Gervois, et al.
Cell Research
|
June 15, 2006
Glucose regulates LXRalpha subcellular localization and function in rat pancreatic beta-cells
Audrey Helleboid-Chapman, Stéphane Helleboid, Heidelinde Jakel, et al.
Page
of 3